Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis

References

• Menzies D, Pai M, Comstock G. New tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340–54
   PubMed Web of Science ®Google Scholar
• Pai M, Zwerling A, Menzies D. T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177–84
   PubMed Web of Science ®Google Scholar
• Mori T. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 2009; 15: 143–55
   PubMedGoogle Scholar
• Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, et al. Usefulness of whole-blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007; 132: 959–65
   PubMed Web of Science ®Google Scholar
• Wang JY, Chou CH, Lee LN, Hsu HL, Jan IS, Hsueh PR, et al. Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-γ. Emerg Infect Dis 2007; 13: 553–8
   PubMed Web of Science ®Google Scholar
• Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, et al. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 2008; 133: 1196–202
   PubMed Web of Science ®Google Scholar
• Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, et al. Clinical evaluation for diagnosing active TB disease and transitional change of two commercial blood tests. Scand J Infect Dis 2008; 40: 629–34
   PubMedGoogle Scholar
• Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328–34
   PubMed Web of Science ®Google Scholar
• Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-γ release assay for detection of active tuberculosis. Clin Infect Dis 2007; 44: 69–73
   PubMed Web of Science ®Google Scholar
• Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-γ release assays in persons with suspected tuberculosis. Clin Infect Dis 2007; 45: 837–45
   PubMedGoogle Scholar
• Chen X, Yang Q, Zhang M, Graner M, Zhu X, Larmonier N, et al. Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol 2009; 16: 879–84
   PubMedGoogle Scholar
• Cellestis. QuantiFERON-TB Gold In-Tube test manufacturer's instructions. Available at:http://www.cellestis.com (accessed 13 June 2009).
   Google Scholar
• Bennett BM. On comparisons of sensitivity, specificity and predictive value of a number of diagnostic procedures. Biometrics 1972; 28: 793–800
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367–416
   PubMed Web of Science ®Google Scholar
• Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54: 49–55
   PubMedGoogle Scholar
• Korean Academy of Tuberculosis and Respiratory Diseases. Guidelines for the Management of Tuberculosis (in Korean). Seoul: Korean Academy of Tuberculosis and Respiratory Diseases; 2005.
   Google Scholar
• Dosanjh DP, Hinks TS, Innes JA, Deeks JJ, Pasvol G, Hackforth S, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008; 148: 325–36
   PubMedGoogle Scholar
• Goletti D, Stefania C, Butera O, Amicosante M, Ernst M, Sauzullo I, et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One 2008; 3: e3417
   Web of Science ®Google Scholar
• Neuenschwander BE, Zwahlen M, Kim SJ, Lee EG, Rieder HL. Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated against bacillus Calmette–Guerin in South Korea. Am J Epidemiol 2002; 155: 654–63
   PubMedGoogle Scholar
• Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45: 322–8
   PubMed Web of Science ®Google Scholar
• Adams LV, Waddell RD, Von Reyn CF. T-SPOT.TB Test® results in adults with Mycobacterium avium complex pulmonary disease. Scand J Infect Dis 2008; 40: 196–203
   PubMed Web of Science ®Google Scholar
• Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis 2006; 43: 1540–6
   PubMed Web of Science ®Google Scholar
• Haimi-Cohen Y, Zeharia A, Mimouni M, Soukhman M, Amir J. Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin Infect Dis 2001; 33: 1786–8
   PubMedGoogle Scholar
• Arend SM, van Meijgaarden KE, de Boer K, de Palou EC, van Soolingen D, Ottenhoff TH, et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002; 186: 1797–807
   PubMed Web of Science ®Google Scholar
• Sonnenberg P, Murray J, Glynn JR, Thomas RG, Godfrey-Faussett P, Shearer S. Risk factors for pulmonary disease due to culture-positive M. tuberculosis or nontuberculous mycobacteria in South African gold miners. Eur Respir J 2000; 15: 291–6
   PubMed Web of Science ®Google Scholar